REBECCA MICHAEL: Open Payments
NPI 1861921371 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,823 in 83 payments from 25 companies in 2025. Trend: 2023 $1,220 · 2024 $2,014 · 2025 $1,823
Food & beverage: $1,823
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $278 |
| ABBVIE INC. | 10 | $205 |
| Astellas Pharma US Inc | 7 | $190 |
| Edwards Lifesciences Corporation | 2 | $162 |
| Radius Health, Inc. | 7 | $148 |
| Novo Nordisk Inc | 12 | $147 |
| Amgen Inc. | 8 | $113 |
| PFIZER INC. | 5 | $101 |
| Corcept Therapeutics | 2 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
Products named: Veozah, BREZTRI, SAPIEN 3 Ultra RESILIA, Tymlos, AIRSUPRA, NURTEC ODT, EVENITY, QULIPTA.
Industry payments across AZ — which companies pay providers there.
